推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 J EXP CLIN CANC最新评论:您好,请问投稿的时候需要上传原始数据吗? (2023-10-16)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH期刊基本信息Hello,您是该期刊的第192982位访客

基本信息 登录收藏
期刊名字JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

J EXP CLIN CANC RES
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.7
60人评分
我要评分

声誉
8.2

影响力
7.0

速度
9.5

期刊ISSN1756-9966
微信扫码收藏此期刊
P-ISSN0392-9078
2022-2023最新影响因子
(数据来源于搜索引擎)
11.3 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:11.21
2022-2023自引率1.80%点击查看自引率趋势图
五年影响因子11.5
h-index 67
CiteScore
CiteScoreSJRSNIPCiteScore排名
20.702.4131.870
学科分区排名百分位
大类:Medicine
小类:Oncology
Q119 / 366
大类:Medicine
小类:Cancer Research
Q113 / 214

期刊简介
Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.
期刊官方网站http://jeccr.biomedcentral.com
期刊投稿网址https://www.editorialmanager.com/jecc/
作者指南网址http://jeccr.biomedcentral.com/submission-guidelines
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH的语言要求,还能让JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP2890; USD3990; EUR3390; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:oncology、cancer、human tumours
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
出版商BioMed Central
涉及的研究方向医学-肿瘤学
出版国家或地区ITALY
出版语言English
出版周期Quarterly
出版年份2008
年文章数 302点击查看年文章数趋势图
Gold OA文章占比99.55%
研究类文章占比:
文章 ÷(文章 + 综述)
83.11%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q124/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区1区2区
ONCOLOGY
肿瘤学
4区3区2区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区2区
ONCOLOGY
肿瘤学
1区4区1区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
ONCOLOGY
肿瘤学
2区3区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-9966%5BISSN%5D
平均审稿速度网友分享经验:
平均1月
平均录用比例网友分享经验:
约66.66%
版面费/APC文章处理费信息
文章处理费:需要( GBP2890; USD3990; EUR3390; )
文章处理费豁免:查看说明
其他费用:没有
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    Nature Reviews Clinical Oncology12775.50
    NATURE REVIEWS CANCER39696.70
    LANCET ONCOLOGY27462.00
    ANNALS OF ONCOLOGY21063.00
    CANCER CELL29552.90
    JOURNAL OF CLINICAL ONCOLOGY49439.60
    SEMINARS IN CANCER BIOLOGY13420.00
    CANCER TREATMENT REVIEWS11620.70
    CLINICAL CANCER RESEARCH29221.80
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE616042
    BIOMATERIALS524037
    BIOMEDICINE & PHARMACOTHERAPY480435
    Journal of Materials Chemistry B467994
    Frontiers in Pharmacology463102
    Frontiers in Immunology435947
    JOURNAL OF ETHNOPHARMACOLOGY417110
    COLLOIDS AND SURFACES B-BIOINTERFACES410872
    Frontiers in Oncology394740
    COMPUTERS IN BIOLOGY AND MEDICINE386438
  •  

    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization

    Author: Zhang, Nasha; Wang, Bowen; Ma, Chi; Zeng, Jiajia; Wang, Teng; Han, Linyu; Yang, Ming
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02654-9
        PubMed      DOI
    2.FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling

    Author: Yang, Yiqi; Zhang, Yibo; Cao, Jieqiong; Su, Zijian; Li, Fu; Zhang, Peiguang; Zhang, Bihui; Liu, Rongzhan; Zhang, Linhao; Xie, Junye; Li, Jingsheng; Zhang, Jinting; Chen, Xiaojia; Hong, An
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02659-4
        PubMed      DOI
    3.Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth

    Author: Jia, Xuechao; Wang, Penglei; Huang, Chuntian; Zhao, Dengyun; Wu, Qiong; Lu, Bingbing; Nie, Wenna; Huang, Limeng; Tian, Xueli; li, Pan; Laster, Kyle Vaughn; Jiang, Yanan; Li, Xiang; Li, Honglin; Dong, Zigang; Liu, Kangdong
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-023-02666-5
        PubMed      DOI
    4.Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development

    Author: Gao, Lixia; Yang, Fan; Tang, Dianyong; Xu, Zhigang; Tang, Yan; Yang, Donglin; Sun, Deping; Chen, Zhongzhu; Teng, Yong
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02574-0
        PubMed      DOI
    5.KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2

    Author: Zhou, Hui; Chen, Junru; Fan, Mingjie; Cai, Huajian; Dong, Yufei; Qiu, Yue; Zhuang, Qianqian; Lei, Zhaoying; Li, Mengyao; Ding, Xue; Yan, Peng; Lin, Aifu; Zheng, Shusen; Yan, Qingfeng
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02562-4
        PubMed      DOI
    6.S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma

    Author: Wang, Xingtong; Guo, Wei; Shi, Xiaoju; Chen, Yujia; Yu, Youxi; Du, Beibei; Tan, Min; Tong, Li; Wang, Anna; Yin, Xianying; Guo, Jing; Martin, Robert C. C.; Bai, Ou; Li, Yan
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02589-7
        PubMed      DOI
    7.Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis

    Author: Li, Yan; Yang, Wenjuan; Zheng, Yuanyuan; Dai, Weiqi; Ji, Jie; Wu, Liwei; Cheng, Ziqi; Zhang, Jie; Li, Jingjing; Xu, Xuanfu; Wu, Jianye; Yang, Mingwei; Feng, Jiao; Guo, Chuanyong
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02567-z
        PubMed      DOI
    8.Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression

    Author: Deng, Min; Zhang, Long; Zheng, Wenying; Chen, Jiale; Du, Nan; Li, Meiqi; Chen, Weiqing; Huang, Yonghong; Zeng, Ning; Song, Yuanbin; Chen, Yongming
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02586-w
        PubMed      DOI
    9.The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer

    Author: Xu, Youqin; Song, Mu; Hong, Ziyang; Chen, Wancheng; Zhang, Qianbing; Zhou, Jianlong; Yang, Chao; He, Zilong; Yu, Juanjuan; Peng, Xiaolin; Zhu, Qiuhong; Li, Shaotian; Ji, Kaiyuan; Liu, Minfeng; Zuo, Qiang
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02581-1
        PubMed      DOI
    10.被撤回的出版物: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer (Retracted article. See vol. 42, 2023)

    Author: Wu, Tangwei; Li, Xiaoyi; Yan, Ge; Tan, Zheqiong; Zhao, Dan; Liu, Shuiyi; Wang, Hui; Xiang, Yuan; Chen, Weiqun; Lu, Hongda; Liao, Xinghua; Li, Yong; Lu, Zhongxin
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2023; Vol. 42, Issue 1, pp. -. DOI: 10.1186/s13046-022-02588-8
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共5条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451